Literature DB >> 25611180

Cystic fibrosis-related oxidative stress and intestinal lipid disorders.

Marie-Laure Kleme1, Emile Levy.   

Abstract

SIGNIFICANCE: Cystic fibrosis (CF) is the most common lethal genetic disorder in the Caucasian people. It is due to the mutation of cystic fibrosis transmembrane conductance regulator (CFTR) gene located on the long arm of the chromosome 7, which encodes for CFTR protein. The latter, an adenosine triphosphate binding cassette, is a transmembrane chloride channel that is also involved in glutathione transport. As glutathione/glutathione disulfide constitutes the most important pool of cellular redox systems, CFTR defects could thus disrupt the intracellular redox balance. Resulting multisystemic diseases are essentially characterized by a chronic respiratory failure, a pancreatic insufficiency, an essential fatty acid deficiency (EFAD), and inadequate levels of antioxidant vitamins. RECENT ADVANCES: The pathophysiology of CF is complex; however, several mechanisms are proposed, including oxidative stress (OxS) whose implication is recognized and has been clearly demonstrated in CF airways. CRITICAL ISSUES: Little is known about OxS intrinsic triggers and its own involvement in intestinal lipid disorders. Despite the regular administration of pancreatic supplements, high-fat high-calorie diets, and antioxidant fat-soluble vitamins, there is a persistence of steatorrhea, EFAD, and harmful OxS. Intriguingly, several trials with elevated doses of antioxidant vitamins have not yielded significant improvements. FUTURE DIRECTIONS: The main sources and self-maintenance of OxS in CF should be clarified to improve treatment of patients. Therefore, this review will discuss the potential sources and study the mechanisms of OxS in the intestine, known to develop various complications, and its involvement in intestinal lipid disorders in CF patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25611180      PMCID: PMC4333637          DOI: 10.1089/ars.2014.6012

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  147 in total

1.  A new iron-sulfur flavoprotein of the respiratory chain. A component of the fatty acid beta oxidation pathway.

Authors:  F J Ruzicka; H Beinert
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

2.  Cystic fibrosis: lysosomal and mitochondrial enzyme activities of lymphoid cell lines.

Authors:  I Antonowicz; W G Sippell; H Shwachman
Journal:  Pediatr Res       Date:  1972-11       Impact factor: 3.756

3.  Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease.

Authors:  Stephanie Van Biervliet; Jean-Pierre Van Biervliet; Eddy Robberecht; Armand Christophe
Journal:  Clin Chem Lab Med       Date:  2010-10-20       Impact factor: 3.694

Review 4.  The electron transfer flavoprotein: ubiquinone oxidoreductases.

Authors:  Nicholas J Watmough; Frank E Frerman
Journal:  Biochim Biophys Acta       Date:  2010-10-16

5.  Reactions of electron-transfer flavoprotein and electron-transfer flavoprotein: ubiquinone oxidoreductase.

Authors:  R R Ramsay; D J Steenkamp; M Husain
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

6.  The Km of NADH dehydrogenase is decreased in mitochondria of cystic fibrosis cells.

Authors:  M C Dechecchi; E Girella; G Cabrini; G Berton
Journal:  Enzyme       Date:  1988

7.  Cross-linking of the electron-transfer flavoprotein to electron-transfer flavoprotein-ubiquinone oxidoreductase with heterobifunctional reagents.

Authors:  D J Steenkamp
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

Review 8.  Redox compartmentalization and cellular stress.

Authors:  D P Jones; Y-M Go
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

9.  Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients.

Authors:  E Lévy; G Lepage; M Bendayan; N Ronco; L Thibault; N Galéano; L Smith; C C Roy
Journal:  J Lipid Res       Date:  1989-08       Impact factor: 5.922

10.  Mitochondrial NADH dehydrogenase in cystic fibrosis: enzyme kinetics in cultured fibroblasts.

Authors:  B L Shapiro; L F Lam; R J Feigal
Journal:  Am J Hum Genet       Date:  1982-11       Impact factor: 11.025

View more
  8 in total

1.  Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.

Authors:  Jessica A Alvarez; Elizabeth Y Chong; Douglas I Walker; Joshua D Chandler; Ellen S Michalski; Ruth E Grossmann; Karan Uppal; Shuzhao Li; Jennifer K Frediani; Rabindra Tirouvanziam; ViLinh T Tran; Vin Tangpricha; Dean P Jones; Thomas R Ziegler
Journal:  Metabolism       Date:  2017-02-11       Impact factor: 8.694

2.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

3.  Protective Effect of Resveratrol on Immortalized Duck Intestinal Epithelial Cells Exposed to H2O2.

Authors:  Ning Zhou; Yong Tian; Hongzhi Wu; Yongqing Cao; Ruiqing Li; Kang Zou; Wenwu Xu; Lizhi Lu
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

4.  CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.

Authors:  Marie L Kleme; Alain Sané; Carole Garofalo; Ernest Seidman; Emmanuelle Brochiero; Yves Berthiaume; Emile Levy
Journal:  Nutrients       Date:  2018-06-27       Impact factor: 5.717

5.  Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis.

Authors:  Mireille Koudoufio; Francis Feldman; Lena Ahmarani; Edgard Delvin; Schohraya Spahis; Yves Desjardins; Emile Levy
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

6.  Increased susceptibility of cystic fibrosis airway epithelial cells to ferroptosis.

Authors:  Pramila Maniam; Ama-Tawiah Essilfie; Murugan Kalimutho; Dora Ling; David M Frazer; Simon Phipps; Gregory J Anderson; David W Reid
Journal:  Biol Res       Date:  2021-12-13       Impact factor: 5.612

7.  Oxidative stress and impaired insulin secretion in cystic fibrosis pig pancreas.

Authors:  Yunxia O'Malley; Mitchell C Coleman; Xingshen Sun; Junying Lei; Jianrong Yao; Casey F Pulliam; Paige Kluz; Michael L McCormick; Yaling Yi; Yumi Imai; John F Engelhardt; Andrew W Norris; Douglas R Spitz; Aliye Uc
Journal:  Adv Redox Res       Date:  2022-06-09

8.  Resveratrol Attenuates Oxidative Stress-Induced Intestinal Barrier Injury through PI3K/Akt-Mediated Nrf2 Signaling Pathway.

Authors:  Yu Zhuang; Huirong Wu; Xiangxiang Wang; Jieyu He; Shanping He; Yulong Yin
Journal:  Oxid Med Cell Longev       Date:  2019-12-02       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.